Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma

Lilit Karapetyan, Jin Xu, Kimberly Ward, Denise Kalos, Benjamin Schachner, Johannes Ali, Xiaofei Song, Joel Kuriakose, MacLean S. Hall, Jamie Chau, Cheryl A. Cox, Ayah N. Al-Bzour, Rana Falahat, Matthew C. Perez, John E. Mullinax, Jonathan S. Zager, Ricardo Gonzalez, Vernon K. Sondak, Kenneth Y. Tsai, Jane L. Messina, Carlos Moran-Segura, Neale Lopez-Blanco, Anthony E. Alleyne, Jonathan V. Nguyen, Michael J. Schell, Joseph Markowitz, Andrew S. Brohl, Zeynep Eroglu, Ahmad A. Tarhini, Nikhil I. Khushalani, Patrick Hwu, James J. Mulé, Amod A. Sarnaik, Matthew S. Beatty, Shari Pilon-Thomas

Open source

DOI: 10.1016/j.medj.2026.101231
Published: 2026-08
Container: Med
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.medj.2026.101231,
  title = {Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma},
  author = {Lilit Karapetyan and Jin Xu and Kimberly Ward and Denise Kalos and Benjamin Schachner and Johannes Ali and Xiaofei Song and Joel Kuriakose and MacLean S. Hall and Jamie Chau and Cheryl A. Cox and Ayah N. Al-Bzour and Rana Falahat and Matthew C. Perez and John E. Mullinax and Jonathan S. Zager and Ricardo Gonzalez and Vernon K. Sondak and Kenneth Y. Tsai and Jane L. Messina and Carlos Moran-Segura and Neale Lopez-Blanco and Anthony E. Alleyne and Jonathan V. Nguyen and Michael J. Schell and Joseph Markowitz and Andrew S. Brohl and Zeynep Eroglu and Ahmad A. Tarhini and Nikhil I. Khushalani and Patrick Hwu and James J. Mulé and Amod A. Sarnaik and Matthew S. Beatty and Shari Pilon-Thomas},
  year = {2026},
  journal = {Med},
  doi = {10.1016/j.medj.2026.101231},
  url = {https://doi.org/10.1016/j.medj.2026.101231}
}

RIS

TY  - JOUR
TI  - Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma
AU  - Lilit Karapetyan
AU  - Jin Xu
AU  - Kimberly Ward
AU  - Denise Kalos
AU  - Benjamin Schachner
AU  - Johannes Ali
AU  - Xiaofei Song
AU  - Joel Kuriakose
AU  - MacLean S. Hall
AU  - Jamie Chau
AU  - Cheryl A. Cox
AU  - Ayah N. Al-Bzour
AU  - Rana Falahat
AU  - Matthew C. Perez
AU  - John E. Mullinax
AU  - Jonathan S. Zager
AU  - Ricardo Gonzalez
AU  - Vernon K. Sondak
AU  - Kenneth Y. Tsai
AU  - Jane L. Messina
AU  - Carlos Moran-Segura
AU  - Neale Lopez-Blanco
AU  - Anthony E. Alleyne
AU  - Jonathan V. Nguyen
AU  - Michael J. Schell
AU  - Joseph Markowitz
AU  - Andrew S. Brohl
AU  - Zeynep Eroglu
AU  - Ahmad A. Tarhini
AU  - Nikhil I. Khushalani
AU  - Patrick Hwu
AU  - James J. Mulé
AU  - Amod A. Sarnaik
AU  - Matthew S. Beatty
AU  - Shari Pilon-Thomas
PY  - 2026
JO  - Med
DO  - 10.1016/j.medj.2026.101231
UR  - https://doi.org/10.1016/j.medj.2026.101231
ER  -

APA

Karapetyan, L., Xu, J., Ward, K., Kalos, D., Schachner, B., Ali, J., Song, X., Kuriakose, J., Hall, M. S., Chau, J., Cox, C. A., Al-Bzour, A. N., Falahat, R., Perez, M. C., Mullinax, J. E., Zager, J. S., Gonzalez, R., Sondak, V. K., Tsai, K. Y., Messina, J. L., Moran-Segura, C., Lopez-Blanco, N., Alleyne, A. E., Nguyen, J. V., Schell, M. J., Markowitz, J., Brohl, A. S., Eroglu, Z., Tarhini, A. A., Khushalani, N. I., Hwu, P., Mulé, J. J., Sarnaik, A. A., Beatty, M. S., & Pilon-Thomas, S. (2026). Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma. Med. https://doi.org/10.1016/j.medj.2026.101231

Source records

crossref · retrieved 2026-09-25T15:20:48.607Z